Japan wellbeing board supports Merck's oral COVID-19 treatment
Japan wellbeing board supports Merck's oral COVID-19 treatment TOKYO, Dec 24 (Reuters) - A Japanese wellbeing serv ice board on Friday suggested endorsement of the COVID-19 antiviral pill created by Merck and Co Inc (MRK.N), a piece of Prime Minister Fumio Kishida's arrangement to carry out new medicines by year-end as worries ascend about the Omicron variation. The board's choice makes way for shipments of 200,000 portions the nation over from this end of the week, in view of arrangements reported before by Kishida.